nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—SULT2A1—prostate cancer	0.232	0.686	CbGaD
Abiraterone—Testosterone—Estramustine—prostate cancer	0.107	0.417	CrCrCtD
Abiraterone—CYP17A1—prostate cancer	0.086	0.254	CbGaD
Abiraterone—Testosterone—Estrone—prostate cancer	0.0847	0.332	CrCrCtD
Abiraterone—Testosterone—Estradiol—prostate cancer	0.0642	0.251	CrCrCtD
Abiraterone—CYP3A4—prostate cancer	0.0206	0.0606	CbGaD
Abiraterone—ABCC1—Conjugated Estrogens—prostate cancer	0.0203	0.0846	CbGbCtD
Abiraterone—CYP2C8—Nilutamide—prostate cancer	0.0185	0.077	CbGbCtD
Abiraterone—ABCC1—Mitoxantrone—prostate cancer	0.0185	0.0769	CbGbCtD
Abiraterone—ABCC1—Epirubicin—prostate cancer	0.0149	0.0623	CbGbCtD
Abiraterone—ALB—Estrone—prostate cancer	0.0143	0.0597	CbGbCtD
Abiraterone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0143	0.0594	CbGbCtD
Abiraterone—CYP2D6—Bicalutamide—prostate cancer	0.0118	0.0491	CbGbCtD
Abiraterone—ABCC1—Etoposide—prostate cancer	0.0116	0.0485	CbGbCtD
Abiraterone—CYP2C8—Cabazitaxel—prostate cancer	0.0113	0.0472	CbGbCtD
Abiraterone—ABCC1—Docetaxel—prostate cancer	0.0106	0.0444	CbGbCtD
Abiraterone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00986	0.0411	CbGbCtD
Abiraterone—ALB—Estradiol—prostate cancer	0.00822	0.0343	CbGbCtD
Abiraterone—ABCC1—Doxorubicin—prostate cancer	0.00794	0.0331	CbGbCtD
Abiraterone—CYP3A4—Bicalutamide—prostate cancer	0.00749	0.0312	CbGbCtD
Abiraterone—ALB—Prednisone—prostate cancer	0.00707	0.0295	CbGbCtD
Abiraterone—CYP3A4—Estramustine—prostate cancer	0.00696	0.029	CbGbCtD
Abiraterone—CYP2C8—Estradiol—prostate cancer	0.00635	0.0265	CbGbCtD
Abiraterone—CYP3A4—Flutamide—prostate cancer	0.00621	0.0259	CbGbCtD
Abiraterone—CYP3A4—Cabazitaxel—prostate cancer	0.00459	0.0191	CbGbCtD
Abiraterone—CYP3A4—Estrone—prostate cancer	0.00449	0.0187	CbGbCtD
Abiraterone—CYP2C8—Etoposide—prostate cancer	0.00415	0.0173	CbGbCtD
Abiraterone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.004	0.0167	CbGbCtD
Abiraterone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00294	0.0122	CbGbCtD
Abiraterone—CYP3A4—Mitoxantrone—prostate cancer	0.00267	0.0111	CbGbCtD
Abiraterone—CYP3A4—Estradiol—prostate cancer	0.00258	0.0107	CbGbCtD
Abiraterone—SULT2A1—prostate gland—prostate cancer	0.00225	0.199	CbGeAlD
Abiraterone—CYP3A4—Prednisone—prostate cancer	0.00222	0.00924	CbGbCtD
Abiraterone—CYP2D6—Doxorubicin—prostate cancer	0.0018	0.00752	CbGbCtD
Abiraterone—CYP3A4—Etoposide—prostate cancer	0.00168	0.00701	CbGbCtD
Abiraterone—CYP3A4—Docetaxel—prostate cancer	0.00154	0.00642	CbGbCtD
Abiraterone—CYP3A4—Doxorubicin—prostate cancer	0.00115	0.00478	CbGbCtD
Abiraterone—SULT2A1—testis—prostate cancer	0.000993	0.0878	CbGeAlD
Abiraterone—CYP3A4—urine—prostate cancer	0.000801	0.0708	CbGeAlD
Abiraterone—CYP2D6—urine—prostate cancer	0.000788	0.0697	CbGeAlD
Abiraterone—SULT2A1—lymph node—prostate cancer	0.00072	0.0636	CbGeAlD
Abiraterone—ORM1—prostate gland—prostate cancer	0.000689	0.0609	CbGeAlD
Abiraterone—CYP17A1—renal system—prostate cancer	0.000669	0.0591	CbGeAlD
Abiraterone—Testosterone—CYP3A43—prostate cancer	0.000511	0.279	CrCbGaD
Abiraterone—ABCC1—prostate gland—prostate cancer	0.000499	0.0441	CbGeAlD
Abiraterone—CYP17A1—testis—prostate cancer	0.000432	0.0382	CbGeAlD
Abiraterone—ABCC1—seminal vesicle—prostate cancer	0.000422	0.0373	CbGeAlD
Abiraterone—ORM1—bone marrow—prostate cancer	0.000355	0.0314	CbGeAlD
Abiraterone—ABCC1—urethra—prostate cancer	0.000334	0.0295	CbGeAlD
Abiraterone—CYP17A1—lymph node—prostate cancer	0.000313	0.0277	CbGeAlD
Abiraterone—CYP2C8—renal system—prostate cancer	0.000289	0.0256	CbGeAlD
Abiraterone—ALB—testis—prostate cancer	0.000266	0.0235	CbGeAlD
Abiraterone—Testosterone—SLC22A3—prostate cancer	0.000221	0.121	CrCbGaD
Abiraterone—ORM1—lymph node—prostate cancer	0.00022	0.0194	CbGeAlD
Abiraterone—ABCC1—testis—prostate cancer	0.00022	0.0194	CbGeAlD
Abiraterone—CYP3A4—renal system—prostate cancer	0.000196	0.0173	CbGeAlD
Abiraterone—ALB—lymph node—prostate cancer	0.000193	0.017	CbGeAlD
Abiraterone—CYP2D6—renal system—prostate cancer	0.000193	0.017	CbGeAlD
Abiraterone—CYP2C8—testis—prostate cancer	0.000187	0.0165	CbGeAlD
Abiraterone—Testosterone—SHBG—prostate cancer	0.000161	0.0879	CrCbGaD
Abiraterone—Testosterone—CYP1B1—prostate cancer	0.000161	0.0879	CrCbGaD
Abiraterone—ABCC1—lymph node—prostate cancer	0.000159	0.0141	CbGeAlD
Abiraterone—Testosterone—SLC22A1—prostate cancer	0.000159	0.0868	CrCbGaD
Abiraterone—Testosterone—AR—prostate cancer	0.000141	0.0771	CrCbGaD
Abiraterone—Testosterone—CYP3A5—prostate cancer	0.000128	0.07	CrCbGaD
Abiraterone—CYP2D6—testis—prostate cancer	0.000125	0.011	CbGeAlD
Abiraterone—Testosterone—CYP19A1—prostate cancer	0.000118	0.0645	CrCbGaD
Abiraterone—Testosterone—CYP2C19—prostate cancer	8.71e-05	0.0477	CrCbGaD
Abiraterone—Testosterone—CYP1A1—prostate cancer	8.68e-05	0.0475	CrCbGaD
Abiraterone—Pneumonia—Capecitabine—prostate cancer	6.24e-05	0.000794	CcSEcCtD
Abiraterone—Mediastinal disorder—Etoposide—prostate cancer	6.24e-05	0.000794	CcSEcCtD
Abiraterone—Infestation NOS—Capecitabine—prostate cancer	6.21e-05	0.000789	CcSEcCtD
Abiraterone—Infestation—Capecitabine—prostate cancer	6.21e-05	0.000789	CcSEcCtD
Abiraterone—Vomiting—Ethinyl Estradiol—prostate cancer	6.19e-05	0.000787	CcSEcCtD
Abiraterone—Chest pain—Mitoxantrone—prostate cancer	6.17e-05	0.000785	CcSEcCtD
Abiraterone—Myalgia—Mitoxantrone—prostate cancer	6.17e-05	0.000785	CcSEcCtD
Abiraterone—Skin disorder—Estradiol—prostate cancer	6.16e-05	0.000784	CcSEcCtD
Abiraterone—Rash—Ethinyl Estradiol—prostate cancer	6.13e-05	0.00078	CcSEcCtD
Abiraterone—Dermatitis—Ethinyl Estradiol—prostate cancer	6.13e-05	0.000779	CcSEcCtD
Abiraterone—Acute coronary syndrome—Capecitabine—prostate cancer	6.12e-05	0.000778	CcSEcCtD
Abiraterone—Discomfort—Mitoxantrone—prostate cancer	6.1e-05	0.000775	CcSEcCtD
Abiraterone—Myocardial infarction—Capecitabine—prostate cancer	6.08e-05	0.000774	CcSEcCtD
Abiraterone—Urinary tract infection—Capecitabine—prostate cancer	6.03e-05	0.000767	CcSEcCtD
Abiraterone—Hot flush—Epirubicin—prostate cancer	6e-05	0.000763	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Doxorubicin—prostate cancer	5.97e-05	0.000759	CcSEcCtD
Abiraterone—Menopausal symptoms—Epirubicin—prostate cancer	5.95e-05	0.000756	CcSEcCtD
Abiraterone—Haematuria—Capecitabine—prostate cancer	5.92e-05	0.000753	CcSEcCtD
Abiraterone—Oedema—Mitoxantrone—prostate cancer	5.91e-05	0.000752	CcSEcCtD
Abiraterone—Infection—Mitoxantrone—prostate cancer	5.88e-05	0.000747	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Estradiol—prostate cancer	5.78e-05	0.000735	CcSEcCtD
Abiraterone—Cardiac failure—Epirubicin—prostate cancer	5.75e-05	0.000731	CcSEcCtD
Abiraterone—Asthenia—Goserelin—prostate cancer	5.74e-05	0.000731	CcSEcCtD
Abiraterone—Skin disorder—Mitoxantrone—prostate cancer	5.74e-05	0.000731	CcSEcCtD
Abiraterone—Insomnia—Estradiol—prostate cancer	5.74e-05	0.00073	CcSEcCtD
Abiraterone—Asthenia—Conjugated Estrogens—prostate cancer	5.69e-05	0.000724	CcSEcCtD
Abiraterone—Urinary tract disorder—Docetaxel—prostate cancer	5.68e-05	0.000723	CcSEcCtD
Abiraterone—Dyspnoea—Estradiol—prostate cancer	5.66e-05	0.00072	CcSEcCtD
Abiraterone—Connective tissue disorder—Docetaxel—prostate cancer	5.65e-05	0.000719	CcSEcCtD
Abiraterone—Urethral disorder—Docetaxel—prostate cancer	5.64e-05	0.000717	CcSEcCtD
Abiraterone—Hyperglycaemia—Prednisone—prostate cancer	5.59e-05	0.000711	CcSEcCtD
Abiraterone—Dyspepsia—Estradiol—prostate cancer	5.59e-05	0.000711	CcSEcCtD
Abiraterone—Anaemia—Etoposide—prostate cancer	5.57e-05	0.000708	CcSEcCtD
Abiraterone—Hot flush—Doxorubicin—prostate cancer	5.55e-05	0.000706	CcSEcCtD
Abiraterone—Testosterone—CYP3A4—prostate cancer	5.54e-05	0.0303	CrCbGaD
Abiraterone—Urinary tract disorder—Capecitabine—prostate cancer	5.5e-05	0.0007	CcSEcCtD
Abiraterone—Menopausal symptoms—Doxorubicin—prostate cancer	5.5e-05	0.0007	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Estradiol—prostate cancer	5.48e-05	0.000697	CcSEcCtD
Abiraterone—Diarrhoea—Goserelin—prostate cancer	5.48e-05	0.000697	CcSEcCtD
Abiraterone—Connective tissue disorder—Capecitabine—prostate cancer	5.47e-05	0.000696	CcSEcCtD
Abiraterone—Fatigue—Estradiol—prostate cancer	5.47e-05	0.000696	CcSEcCtD
Abiraterone—Urethral disorder—Capecitabine—prostate cancer	5.46e-05	0.000695	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisone—prostate cancer	5.45e-05	0.000693	CcSEcCtD
Abiraterone—Constipation—Estradiol—prostate cancer	5.43e-05	0.00069	CcSEcCtD
Abiraterone—Diarrhoea—Conjugated Estrogens—prostate cancer	5.43e-05	0.00069	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisone—prostate cancer	5.42e-05	0.000689	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	5.39e-05	0.000685	CcSEcCtD
Abiraterone—Cardiac disorder—Docetaxel—prostate cancer	5.34e-05	0.000679	CcSEcCtD
Abiraterone—Cardiac failure—Doxorubicin—prostate cancer	5.32e-05	0.000676	CcSEcCtD
Abiraterone—Dyspnoea—Mitoxantrone—prostate cancer	5.27e-05	0.000671	CcSEcCtD
Abiraterone—Cough—Etoposide—prostate cancer	5.26e-05	0.000669	CcSEcCtD
Abiraterone—Angiopathy—Docetaxel—prostate cancer	5.22e-05	0.000664	CcSEcCtD
Abiraterone—Dyspepsia—Mitoxantrone—prostate cancer	5.21e-05	0.000662	CcSEcCtD
Abiraterone—Hypertension—Etoposide—prostate cancer	5.2e-05	0.000662	CcSEcCtD
Abiraterone—Mediastinal disorder—Docetaxel—prostate cancer	5.19e-05	0.00066	CcSEcCtD
Abiraterone—Cardiac disorder—Capecitabine—prostate cancer	5.17e-05	0.000658	CcSEcCtD
Abiraterone—Arrhythmia—Docetaxel—prostate cancer	5.14e-05	0.000654	CcSEcCtD
Abiraterone—Chest pain—Etoposide—prostate cancer	5.13e-05	0.000653	CcSEcCtD
Abiraterone—Hypokalaemia—Epirubicin—prostate cancer	5.11e-05	0.000649	CcSEcCtD
Abiraterone—Fatigue—Mitoxantrone—prostate cancer	5.1e-05	0.000648	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	5.1e-05	0.000648	CcSEcCtD
Abiraterone—Vomiting—Goserelin—prostate cancer	5.09e-05	0.000647	CcSEcCtD
Abiraterone—Discomfort—Etoposide—prostate cancer	5.07e-05	0.000645	CcSEcCtD
Abiraterone—Constipation—Mitoxantrone—prostate cancer	5.06e-05	0.000643	CcSEcCtD
Abiraterone—Angiopathy—Capecitabine—prostate cancer	5.05e-05	0.000643	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Epirubicin—prostate cancer	5.05e-05	0.000642	CcSEcCtD
Abiraterone—Rash—Goserelin—prostate cancer	5.05e-05	0.000642	CcSEcCtD
Abiraterone—Dermatitis—Goserelin—prostate cancer	5.04e-05	0.000641	CcSEcCtD
Abiraterone—Vomiting—Conjugated Estrogens—prostate cancer	5.04e-05	0.000641	CcSEcCtD
Abiraterone—Mental disorder—Docetaxel—prostate cancer	5.04e-05	0.000641	CcSEcCtD
Abiraterone—Mediastinal disorder—Capecitabine—prostate cancer	5.02e-05	0.000639	CcSEcCtD
Abiraterone—Body temperature increased—Estradiol—prostate cancer	5.02e-05	0.000638	CcSEcCtD
Abiraterone—Nasopharyngitis—Epirubicin—prostate cancer	5.02e-05	0.000638	CcSEcCtD
Abiraterone—Rash—Conjugated Estrogens—prostate cancer	5e-05	0.000636	CcSEcCtD
Abiraterone—Dermatitis—Conjugated Estrogens—prostate cancer	5e-05	0.000635	CcSEcCtD
Abiraterone—Arrhythmia—Capecitabine—prostate cancer	4.98e-05	0.000633	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Epirubicin—prostate cancer	4.95e-05	0.000629	CcSEcCtD
Abiraterone—Infection—Etoposide—prostate cancer	4.89e-05	0.000622	CcSEcCtD
Abiraterone—Mental disorder—Capecitabine—prostate cancer	4.88e-05	0.000621	CcSEcCtD
Abiraterone—Connective tissue disorder—Prednisone—prostate cancer	4.88e-05	0.00062	CcSEcCtD
Abiraterone—Skin disorder—Etoposide—prostate cancer	4.78e-05	0.000608	CcSEcCtD
Abiraterone—Hypokalaemia—Doxorubicin—prostate cancer	4.72e-05	0.000601	CcSEcCtD
Abiraterone—Body temperature increased—Mitoxantrone—prostate cancer	4.67e-05	0.000595	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	4.67e-05	0.000594	CcSEcCtD
Abiraterone—Nasopharyngitis—Doxorubicin—prostate cancer	4.64e-05	0.00059	CcSEcCtD
Abiraterone—Anaemia—Docetaxel—prostate cancer	4.63e-05	0.000589	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Doxorubicin—prostate cancer	4.58e-05	0.000582	CcSEcCtD
Abiraterone—Asthenia—Estradiol—prostate cancer	4.55e-05	0.000579	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Epirubicin—prostate cancer	4.51e-05	0.000573	CcSEcCtD
Abiraterone—Angiopathy—Prednisone—prostate cancer	4.5e-05	0.000573	CcSEcCtD
Abiraterone—Anaemia—Capecitabine—prostate cancer	4.48e-05	0.00057	CcSEcCtD
Abiraterone—Pollakiuria—Epirubicin—prostate cancer	4.48e-05	0.00057	CcSEcCtD
Abiraterone—Arrhythmia—Prednisone—prostate cancer	4.43e-05	0.000564	CcSEcCtD
Abiraterone—Dyspnoea—Etoposide—prostate cancer	4.39e-05	0.000558	CcSEcCtD
Abiraterone—Hyperglycaemia—Epirubicin—prostate cancer	4.37e-05	0.000556	CcSEcCtD
Abiraterone—Cough—Docetaxel—prostate cancer	4.37e-05	0.000556	CcSEcCtD
Abiraterone—Pneumonia—Epirubicin—prostate cancer	4.35e-05	0.000553	CcSEcCtD
Abiraterone—Mental disorder—Prednisone—prostate cancer	4.35e-05	0.000553	CcSEcCtD
Abiraterone—Diarrhoea—Estradiol—prostate cancer	4.34e-05	0.000552	CcSEcCtD
Abiraterone—Hypertension—Docetaxel—prostate cancer	4.32e-05	0.00055	CcSEcCtD
Abiraterone—Infestation NOS—Epirubicin—prostate cancer	4.32e-05	0.00055	CcSEcCtD
Abiraterone—Infestation—Epirubicin—prostate cancer	4.32e-05	0.00055	CcSEcCtD
Abiraterone—Chest pain—Docetaxel—prostate cancer	4.26e-05	0.000542	CcSEcCtD
Abiraterone—Myalgia—Docetaxel—prostate cancer	4.26e-05	0.000542	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Etoposide—prostate cancer	4.25e-05	0.00054	CcSEcCtD
Abiraterone—Asthenia—Mitoxantrone—prostate cancer	4.24e-05	0.00054	CcSEcCtD
Abiraterone—Fatigue—Etoposide—prostate cancer	4.24e-05	0.000539	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.24e-05	0.000539	CcSEcCtD
Abiraterone—Cough—Capecitabine—prostate cancer	4.23e-05	0.000538	CcSEcCtD
Abiraterone—Constipation—Etoposide—prostate cancer	4.21e-05	0.000535	CcSEcCtD
Abiraterone—Urinary tract infection—Epirubicin—prostate cancer	4.2e-05	0.000534	CcSEcCtD
Abiraterone—Hypertension—Capecitabine—prostate cancer	4.19e-05	0.000532	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.17e-05	0.00053	CcSEcCtD
Abiraterone—Pollakiuria—Doxorubicin—prostate cancer	4.14e-05	0.000527	CcSEcCtD
Abiraterone—Myalgia—Capecitabine—prostate cancer	4.13e-05	0.000525	CcSEcCtD
Abiraterone—Chest pain—Capecitabine—prostate cancer	4.13e-05	0.000525	CcSEcCtD
Abiraterone—Haematuria—Epirubicin—prostate cancer	4.12e-05	0.000524	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.1e-05	0.000521	CcSEcCtD
Abiraterone—Oedema—Docetaxel—prostate cancer	4.09e-05	0.00052	CcSEcCtD
Abiraterone—Discomfort—Capecitabine—prostate cancer	4.08e-05	0.000519	CcSEcCtD
Abiraterone—Infection—Docetaxel—prostate cancer	4.06e-05	0.000517	CcSEcCtD
Abiraterone—Hyperglycaemia—Doxorubicin—prostate cancer	4.05e-05	0.000515	CcSEcCtD
Abiraterone—Diarrhoea—Mitoxantrone—prostate cancer	4.05e-05	0.000515	CcSEcCtD
Abiraterone—Vomiting—Estradiol—prostate cancer	4.04e-05	0.000513	CcSEcCtD
Abiraterone—Pneumonia—Doxorubicin—prostate cancer	4.02e-05	0.000512	CcSEcCtD
Abiraterone—Rash—Estradiol—prostate cancer	4e-05	0.000509	CcSEcCtD
Abiraterone—Infestation—Doxorubicin—prostate cancer	4e-05	0.000509	CcSEcCtD
Abiraterone—Infestation NOS—Doxorubicin—prostate cancer	4e-05	0.000509	CcSEcCtD
Abiraterone—Dermatitis—Estradiol—prostate cancer	4e-05	0.000508	CcSEcCtD
Abiraterone—Anaemia—Prednisone—prostate cancer	3.99e-05	0.000508	CcSEcCtD
Abiraterone—Skin disorder—Docetaxel—prostate cancer	3.97e-05	0.000505	CcSEcCtD
Abiraterone—Oedema—Capecitabine—prostate cancer	3.96e-05	0.000503	CcSEcCtD
Abiraterone—Infection—Capecitabine—prostate cancer	3.93e-05	0.0005	CcSEcCtD
Abiraterone—Body temperature increased—Etoposide—prostate cancer	3.89e-05	0.000495	CcSEcCtD
Abiraterone—Urinary tract infection—Doxorubicin—prostate cancer	3.89e-05	0.000495	CcSEcCtD
Abiraterone—Skin disorder—Capecitabine—prostate cancer	3.84e-05	0.000489	CcSEcCtD
Abiraterone—Urinary tract disorder—Epirubicin—prostate cancer	3.83e-05	0.000487	CcSEcCtD
Abiraterone—Haematuria—Doxorubicin—prostate cancer	3.81e-05	0.000485	CcSEcCtD
Abiraterone—Connective tissue disorder—Epirubicin—prostate cancer	3.81e-05	0.000485	CcSEcCtD
Abiraterone—Urethral disorder—Epirubicin—prostate cancer	3.8e-05	0.000484	CcSEcCtD
Abiraterone—Vomiting—Mitoxantrone—prostate cancer	3.76e-05	0.000478	CcSEcCtD
Abiraterone—Hypertension—Prednisone—prostate cancer	3.73e-05	0.000474	CcSEcCtD
Abiraterone—Rash—Mitoxantrone—prostate cancer	3.73e-05	0.000474	CcSEcCtD
Abiraterone—Dermatitis—Mitoxantrone—prostate cancer	3.73e-05	0.000474	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.72e-05	0.000474	CcSEcCtD
Abiraterone—Insomnia—Docetaxel—prostate cancer	3.7e-05	0.00047	CcSEcCtD
Abiraterone—Myalgia—Prednisone—prostate cancer	3.68e-05	0.000468	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.65e-05	0.000465	CcSEcCtD
Abiraterone—Dyspnoea—Docetaxel—prostate cancer	3.64e-05	0.000464	CcSEcCtD
Abiraterone—Discomfort—Prednisone—prostate cancer	3.63e-05	0.000462	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.61e-05	0.000459	CcSEcCtD
Abiraterone—Cardiac disorder—Epirubicin—prostate cancer	3.6e-05	0.000458	CcSEcCtD
Abiraterone—Dyspepsia—Docetaxel—prostate cancer	3.6e-05	0.000458	CcSEcCtD
Abiraterone—Insomnia—Capecitabine—prostate cancer	3.58e-05	0.000455	CcSEcCtD
Abiraterone—Urinary tract disorder—Doxorubicin—prostate cancer	3.55e-05	0.000451	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Docetaxel—prostate cancer	3.53e-05	0.000449	CcSEcCtD
Abiraterone—Asthenia—Etoposide—prostate cancer	3.53e-05	0.000449	CcSEcCtD
Abiraterone—Connective tissue disorder—Doxorubicin—prostate cancer	3.53e-05	0.000449	CcSEcCtD
Abiraterone—Dyspnoea—Capecitabine—prostate cancer	3.53e-05	0.000449	CcSEcCtD
Abiraterone—Oedema—Prednisone—prostate cancer	3.53e-05	0.000448	CcSEcCtD
Abiraterone—Fatigue—Docetaxel—prostate cancer	3.52e-05	0.000448	CcSEcCtD
Abiraterone—Angiopathy—Epirubicin—prostate cancer	3.52e-05	0.000448	CcSEcCtD
Abiraterone—Urethral disorder—Doxorubicin—prostate cancer	3.52e-05	0.000448	CcSEcCtD
Abiraterone—Infection—Prednisone—prostate cancer	3.5e-05	0.000445	CcSEcCtD
Abiraterone—Mediastinal disorder—Epirubicin—prostate cancer	3.5e-05	0.000445	CcSEcCtD
Abiraterone—Constipation—Docetaxel—prostate cancer	3.5e-05	0.000445	CcSEcCtD
Abiraterone—Dyspepsia—Capecitabine—prostate cancer	3.48e-05	0.000443	CcSEcCtD
Abiraterone—Arrhythmia—Epirubicin—prostate cancer	3.47e-05	0.000441	CcSEcCtD
Abiraterone—Skin disorder—Prednisone—prostate cancer	3.42e-05	0.000436	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.42e-05	0.000435	CcSEcCtD
Abiraterone—Fatigue—Capecitabine—prostate cancer	3.41e-05	0.000434	CcSEcCtD
Abiraterone—Mental disorder—Epirubicin—prostate cancer	3.4e-05	0.000432	CcSEcCtD
Abiraterone—Constipation—Capecitabine—prostate cancer	3.38e-05	0.00043	CcSEcCtD
Abiraterone—Diarrhoea—Etoposide—prostate cancer	3.37e-05	0.000428	CcSEcCtD
Abiraterone—Cardiac disorder—Doxorubicin—prostate cancer	3.33e-05	0.000424	CcSEcCtD
Abiraterone—Angiopathy—Doxorubicin—prostate cancer	3.26e-05	0.000414	CcSEcCtD
Abiraterone—Mediastinal disorder—Doxorubicin—prostate cancer	3.24e-05	0.000412	CcSEcCtD
Abiraterone—Body temperature increased—Docetaxel—prostate cancer	3.23e-05	0.000411	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.21e-05	0.000409	CcSEcCtD
Abiraterone—Arrhythmia—Doxorubicin—prostate cancer	3.21e-05	0.000408	CcSEcCtD
Abiraterone—Insomnia—Prednisone—prostate cancer	3.19e-05	0.000406	CcSEcCtD
Abiraterone—Mental disorder—Doxorubicin—prostate cancer	3.15e-05	0.0004	CcSEcCtD
Abiraterone—Body temperature increased—Capecitabine—prostate cancer	3.13e-05	0.000398	CcSEcCtD
Abiraterone—Vomiting—Etoposide—prostate cancer	3.13e-05	0.000398	CcSEcCtD
Abiraterone—Anaemia—Epirubicin—prostate cancer	3.12e-05	0.000397	CcSEcCtD
Abiraterone—Dyspepsia—Prednisone—prostate cancer	3.1e-05	0.000395	CcSEcCtD
Abiraterone—Rash—Etoposide—prostate cancer	3.1e-05	0.000394	CcSEcCtD
Abiraterone—Dermatitis—Etoposide—prostate cancer	3.1e-05	0.000394	CcSEcCtD
Abiraterone—Fatigue—Prednisone—prostate cancer	3.04e-05	0.000387	CcSEcCtD
Abiraterone—Constipation—Prednisone—prostate cancer	3.01e-05	0.000383	CcSEcCtD
Abiraterone—Cough—Epirubicin—prostate cancer	2.95e-05	0.000375	CcSEcCtD
Abiraterone—Asthenia—Docetaxel—prostate cancer	2.93e-05	0.000373	CcSEcCtD
Abiraterone—Hypertension—Epirubicin—prostate cancer	2.92e-05	0.000371	CcSEcCtD
Abiraterone—Anaemia—Doxorubicin—prostate cancer	2.89e-05	0.000367	CcSEcCtD
Abiraterone—Myalgia—Epirubicin—prostate cancer	2.88e-05	0.000366	CcSEcCtD
Abiraterone—Chest pain—Epirubicin—prostate cancer	2.88e-05	0.000366	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.86e-05	0.000363	CcSEcCtD
Abiraterone—Discomfort—Epirubicin—prostate cancer	2.84e-05	0.000361	CcSEcCtD
Abiraterone—Asthenia—Capecitabine—prostate cancer	2.84e-05	0.000361	CcSEcCtD
Abiraterone—Diarrhoea—Docetaxel—prostate cancer	2.8e-05	0.000356	CcSEcCtD
Abiraterone—Body temperature increased—Prednisone—prostate cancer	2.79e-05	0.000354	CcSEcCtD
Abiraterone—Oedema—Epirubicin—prostate cancer	2.76e-05	0.000351	CcSEcCtD
Abiraterone—Infection—Epirubicin—prostate cancer	2.74e-05	0.000348	CcSEcCtD
Abiraterone—Cough—Doxorubicin—prostate cancer	2.73e-05	0.000347	CcSEcCtD
Abiraterone—Diarrhoea—Capecitabine—prostate cancer	2.71e-05	0.000344	CcSEcCtD
Abiraterone—Hypertension—Doxorubicin—prostate cancer	2.7e-05	0.000343	CcSEcCtD
Abiraterone—Skin disorder—Epirubicin—prostate cancer	2.68e-05	0.000341	CcSEcCtD
Abiraterone—Chest pain—Doxorubicin—prostate cancer	2.66e-05	0.000338	CcSEcCtD
Abiraterone—Myalgia—Doxorubicin—prostate cancer	2.66e-05	0.000338	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.64e-05	0.000336	CcSEcCtD
Abiraterone—Discomfort—Doxorubicin—prostate cancer	2.63e-05	0.000334	CcSEcCtD
Abiraterone—Vomiting—Docetaxel—prostate cancer	2.6e-05	0.000331	CcSEcCtD
Abiraterone—Rash—Docetaxel—prostate cancer	2.58e-05	0.000328	CcSEcCtD
Abiraterone—Dermatitis—Docetaxel—prostate cancer	2.58e-05	0.000328	CcSEcCtD
Abiraterone—Oedema—Doxorubicin—prostate cancer	2.55e-05	0.000324	CcSEcCtD
Abiraterone—Infection—Doxorubicin—prostate cancer	2.53e-05	0.000322	CcSEcCtD
Abiraterone—Asthenia—Prednisone—prostate cancer	2.53e-05	0.000322	CcSEcCtD
Abiraterone—Vomiting—Capecitabine—prostate cancer	2.52e-05	0.00032	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.51e-05	0.000319	CcSEcCtD
Abiraterone—Rash—Capecitabine—prostate cancer	2.5e-05	0.000317	CcSEcCtD
Abiraterone—Insomnia—Epirubicin—prostate cancer	2.49e-05	0.000317	CcSEcCtD
Abiraterone—Dermatitis—Capecitabine—prostate cancer	2.49e-05	0.000317	CcSEcCtD
Abiraterone—Skin disorder—Doxorubicin—prostate cancer	2.48e-05	0.000315	CcSEcCtD
Abiraterone—Dyspnoea—Epirubicin—prostate cancer	2.46e-05	0.000313	CcSEcCtD
Abiraterone—Dyspepsia—Epirubicin—prostate cancer	2.43e-05	0.000309	CcSEcCtD
Abiraterone—Diarrhoea—Prednisone—prostate cancer	2.41e-05	0.000307	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.38e-05	0.000303	CcSEcCtD
Abiraterone—Fatigue—Epirubicin—prostate cancer	2.38e-05	0.000302	CcSEcCtD
Abiraterone—Constipation—Epirubicin—prostate cancer	2.36e-05	0.0003	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.32e-05	0.000296	CcSEcCtD
Abiraterone—Insomnia—Doxorubicin—prostate cancer	2.31e-05	0.000293	CcSEcCtD
Abiraterone—Dyspnoea—Doxorubicin—prostate cancer	2.27e-05	0.000289	CcSEcCtD
Abiraterone—Dyspepsia—Doxorubicin—prostate cancer	2.25e-05	0.000286	CcSEcCtD
Abiraterone—Vomiting—Prednisone—prostate cancer	2.24e-05	0.000285	CcSEcCtD
Abiraterone—Rash—Prednisone—prostate cancer	2.22e-05	0.000283	CcSEcCtD
Abiraterone—Dermatitis—Prednisone—prostate cancer	2.22e-05	0.000282	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.2e-05	0.00028	CcSEcCtD
Abiraterone—Fatigue—Doxorubicin—prostate cancer	2.2e-05	0.00028	CcSEcCtD
Abiraterone—Constipation—Doxorubicin—prostate cancer	2.18e-05	0.000277	CcSEcCtD
Abiraterone—Body temperature increased—Epirubicin—prostate cancer	2.18e-05	0.000277	CcSEcCtD
Abiraterone—Body temperature increased—Doxorubicin—prostate cancer	2.02e-05	0.000257	CcSEcCtD
Abiraterone—Asthenia—Epirubicin—prostate cancer	1.98e-05	0.000252	CcSEcCtD
Abiraterone—Diarrhoea—Epirubicin—prostate cancer	1.89e-05	0.00024	CcSEcCtD
Abiraterone—Asthenia—Doxorubicin—prostate cancer	1.83e-05	0.000233	CcSEcCtD
Abiraterone—Vomiting—Epirubicin—prostate cancer	1.75e-05	0.000223	CcSEcCtD
Abiraterone—Diarrhoea—Doxorubicin—prostate cancer	1.75e-05	0.000222	CcSEcCtD
Abiraterone—Rash—Epirubicin—prostate cancer	1.74e-05	0.000221	CcSEcCtD
Abiraterone—Dermatitis—Epirubicin—prostate cancer	1.74e-05	0.000221	CcSEcCtD
Abiraterone—Vomiting—Doxorubicin—prostate cancer	1.62e-05	0.000206	CcSEcCtD
Abiraterone—Rash—Doxorubicin—prostate cancer	1.61e-05	0.000205	CcSEcCtD
Abiraterone—Dermatitis—Doxorubicin—prostate cancer	1.61e-05	0.000204	CcSEcCtD
Abiraterone—ABCC1—Metabolism—CAV1—prostate cancer	1.96e-06	2.65e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTEN—prostate cancer	1.96e-06	2.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP17A1—prostate cancer	1.95e-06	2.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.94e-06	2.63e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP17A1—prostate cancer	1.94e-06	2.62e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—JAK2—prostate cancer	1.93e-06	2.61e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.92e-06	2.6e-05	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.92e-06	2.6e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MED12—prostate cancer	1.91e-06	2.59e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.91e-06	2.59e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNG5—prostate cancer	1.9e-06	2.57e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAP2K1—prostate cancer	1.88e-06	2.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.88e-06	2.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACSL4—prostate cancer	1.88e-06	2.55e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CD—prostate cancer	1.87e-06	2.53e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.87e-06	2.53e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—EP300—prostate cancer	1.87e-06	2.53e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA2—prostate cancer	1.86e-06	2.51e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—prostate cancer	1.85e-06	2.51e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA2—prostate cancer	1.85e-06	2.5e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CB—prostate cancer	1.83e-06	2.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA3—prostate cancer	1.83e-06	2.47e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UMPS—prostate cancer	1.8e-06	2.44e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ARG2—prostate cancer	1.8e-06	2.44e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PHGDH—prostate cancer	1.8e-06	2.44e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—FGF2—prostate cancer	1.79e-06	2.43e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—prostate cancer	1.78e-06	2.41e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC5A5—prostate cancer	1.77e-06	2.4e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LDHB—prostate cancer	1.77e-06	2.39e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.77e-06	2.39e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—prostate cancer	1.77e-06	2.39e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC5A5—prostate cancer	1.76e-06	2.39e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HPGDS—prostate cancer	1.74e-06	2.36e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.73e-06	2.35e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.73e-06	2.34e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2E1—prostate cancer	1.73e-06	2.34e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2E1—prostate cancer	1.72e-06	2.33e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—JAK2—prostate cancer	1.72e-06	2.33e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NQO1—prostate cancer	1.71e-06	2.32e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NQO1—prostate cancer	1.7e-06	2.3e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTT1—prostate cancer	1.69e-06	2.29e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ACHE—prostate cancer	1.69e-06	2.29e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—INS—prostate cancer	1.69e-06	2.29e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TH—prostate cancer	1.69e-06	2.28e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IL2—prostate cancer	1.68e-06	2.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MDM2—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TH—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TCN2—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UCP3—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PDHA1—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA3—prostate cancer	1.68e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.67e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.67e-06	2.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP3A4—prostate cancer	1.67e-06	2.26e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.67e-06	2.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.66e-06	2.25e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP3A4—prostate cancer	1.66e-06	2.25e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CREBBP—prostate cancer	1.65e-06	2.24e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—ERBB2—prostate cancer	1.65e-06	2.24e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.65e-06	2.24e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1B1—prostate cancer	1.64e-06	2.22e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CB—prostate cancer	1.63e-06	2.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1B1—prostate cancer	1.63e-06	2.21e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.62e-06	2.2e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PRKACB—prostate cancer	1.62e-06	2.19e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—prostate cancer	1.62e-06	2.19e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.6e-06	2.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.6e-06	2.17e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.6e-06	2.17e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GGT1—prostate cancer	1.59e-06	2.15e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GGT1—prostate cancer	1.58e-06	2.14e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CD—prostate cancer	1.57e-06	2.12e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NCOA1—prostate cancer	1.56e-06	2.12e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NCOA1—prostate cancer	1.56e-06	2.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP19A1—prostate cancer	1.54e-06	2.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP19A1—prostate cancer	1.53e-06	2.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.53e-06	2.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA4—prostate cancer	1.53e-06	2.08e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1B—prostate cancer	1.53e-06	2.07e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA2—prostate cancer	1.52e-06	2.06e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—EP300—prostate cancer	1.51e-06	2.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA2—prostate cancer	1.49e-06	2.02e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—RXRA—prostate cancer	1.49e-06	2.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—prostate cancer	1.48e-06	2e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—RXRA—prostate cancer	1.48e-06	2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.48e-06	2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG5—prostate cancer	1.48e-06	2e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SRC—prostate cancer	1.47e-06	1.99e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.45e-06	1.97e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.45e-06	1.96e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CTNNB1—prostate cancer	1.45e-06	1.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.44e-06	1.95e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.44e-06	1.95e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—COMT—prostate cancer	1.43e-06	1.94e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—prostate cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTP1—prostate cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—COMT—prostate cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.42e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.42e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAT2—prostate cancer	1.42e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.42e-06	1.92e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTP1—prostate cancer	1.42e-06	1.92e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CDKN1A—prostate cancer	1.41e-06	1.91e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTEN—prostate cancer	1.41e-06	1.91e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NQO1—prostate cancer	1.4e-06	1.9e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ITPR1—prostate cancer	1.4e-06	1.9e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ITPR1—prostate cancer	1.4e-06	1.89e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TH—prostate cancer	1.38e-06	1.87e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PIK3CA—prostate cancer	1.38e-06	1.87e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.38e-06	1.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.37e-06	1.86e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CB—prostate cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LRP2—prostate cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.37e-06	1.85e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—prostate cancer	1.35e-06	1.83e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.35e-06	1.82e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EP300—prostate cancer	1.34e-06	1.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—P4HB—prostate cancer	1.34e-06	1.81e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—TYMS—prostate cancer	1.33e-06	1.8e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—TYMS—prostate cancer	1.32e-06	1.79e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—prostate cancer	1.31e-06	1.78e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—prostate cancer	1.31e-06	1.78e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SRC—prostate cancer	1.31e-06	1.77e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GGT1—prostate cancer	1.3e-06	1.77e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—prostate cancer	1.3e-06	1.77e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.3e-06	1.77e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LPL—prostate cancer	1.29e-06	1.74e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NCOA1—prostate cancer	1.28e-06	1.74e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LPL—prostate cancer	1.28e-06	1.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.27e-06	1.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.27e-06	1.71e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—prostate cancer	1.26e-06	1.71e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MED12—prostate cancer	1.25e-06	1.69e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.24e-06	1.68e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNG5—prostate cancer	1.24e-06	1.68e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A1—prostate cancer	1.24e-06	1.67e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ERCC2—prostate cancer	1.23e-06	1.67e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ERCC2—prostate cancer	1.23e-06	1.66e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—RXRA—prostate cancer	1.22e-06	1.65e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—KRAS—prostate cancer	1.21e-06	1.64e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.19e-06	1.62e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTEN—prostate cancer	1.18e-06	1.6e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—COMT—prostate cancer	1.18e-06	1.59e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MYC—prostate cancer	1.17e-06	1.59e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTP1—prostate cancer	1.17e-06	1.59e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—prostate cancer	1.17e-06	1.58e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—prostate cancer	1.16e-06	1.57e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ITPR1—prostate cancer	1.15e-06	1.56e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—prostate cancer	1.15e-06	1.56e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—prostate cancer	1.15e-06	1.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.14e-06	1.54e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARA—prostate cancer	1.14e-06	1.54e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.13e-06	1.53e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARA—prostate cancer	1.13e-06	1.53e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—prostate cancer	1.13e-06	1.53e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—EP300—prostate cancer	1.13e-06	1.52e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CA—prostate cancer	1.12e-06	1.51e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACHE—prostate cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.09e-06	1.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—TYMS—prostate cancer	1.09e-06	1.47e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—KRAS—prostate cancer	1.08e-06	1.47e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TP53—prostate cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—prostate cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAV1—prostate cancer	1.07e-06	1.45e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAV1—prostate cancer	1.06e-06	1.44e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.06e-06	1.44e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.06e-06	1.43e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LPL—prostate cancer	1.06e-06	1.43e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.05e-06	1.42e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.01e-06	1.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA2—prostate cancer	9.96e-07	1.35e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3CA—prostate cancer	9.94e-07	1.35e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.73e-07	1.32e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—prostate cancer	9.68e-07	1.31e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—prostate cancer	9.51e-07	1.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.51e-07	1.29e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARA—prostate cancer	9.33e-07	1.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2E1—prostate cancer	9.28e-07	1.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—INS—prostate cancer	9.21e-07	1.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NQO1—prostate cancer	9.18e-07	1.24e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—INS—prostate cancer	9.16e-07	1.24e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—prostate cancer	9.11e-07	1.23e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TH—prostate cancer	9.05e-07	1.23e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CREBBP—prostate cancer	9.02e-07	1.22e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CREBBP—prostate cancer	8.97e-07	1.22e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—prostate cancer	8.8e-07	1.19e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.8e-07	1.19e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAV1—prostate cancer	8.77e-07	1.19e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.56e-07	1.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GGT1—prostate cancer	8.52e-07	1.15e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CD—prostate cancer	8.51e-07	1.15e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA1—prostate cancer	8.4e-07	1.14e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CA—prostate cancer	8.33e-07	1.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.27e-07	1.12e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—prostate cancer	8.12e-07	1.1e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—prostate cancer	8.08e-07	1.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—prostate cancer	8.03e-07	1.09e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—prostate cancer	7.99e-07	1.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—RXRA—prostate cancer	7.99e-07	1.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—COMT—prostate cancer	7.69e-07	1.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTP1—prostate cancer	7.66e-07	1.04e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—INS—prostate cancer	7.56e-07	1.02e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ITPR1—prostate cancer	7.53e-07	1.02e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.46e-07	1.01e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CB—prostate cancer	7.42e-07	1e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CREBBP—prostate cancer	7.41e-07	1e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—prostate cancer	7.39e-07	1e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—prostate cancer	7.35e-07	9.95e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—TYMS—prostate cancer	7.12e-07	9.64e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—prostate cancer	7.04e-07	9.53e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CD—prostate cancer	7.02e-07	9.52e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPL—prostate cancer	6.91e-07	9.36e-06	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—prostate cancer	6.8e-07	9.21e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.67e-07	9.04e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—prostate cancer	6.63e-07	8.99e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ERCC2—prostate cancer	6.62e-07	8.96e-06	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTEN—prostate cancer	6.44e-07	8.73e-06	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTEN—prostate cancer	6.41e-07	8.68e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—prostate cancer	6.22e-07	8.42e-06	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—EP300—prostate cancer	6.15e-07	8.33e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CB—prostate cancer	6.12e-07	8.29e-06	CbGpPWpGaD
Abiraterone—ALB—Metabolism—EP300—prostate cancer	6.11e-07	8.28e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARA—prostate cancer	6.1e-07	8.26e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—prostate cancer	6.07e-07	8.22e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAV1—prostate cancer	5.74e-07	7.77e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTEN—prostate cancer	5.29e-07	7.17e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.22e-07	7.08e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—EP300—prostate cancer	5.05e-07	6.84e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—INS—prostate cancer	4.95e-07	6.7e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CREBBP—prostate cancer	4.84e-07	6.56e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.59e-07	6.22e-06	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.55e-07	6.16e-06	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CA—prostate cancer	4.52e-07	6.12e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—prostate cancer	4.34e-07	5.88e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CB—prostate cancer	4e-07	5.42e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—prostate cancer	3.97e-07	5.37e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.73e-07	5.06e-06	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—prostate cancer	3.71e-07	5.03e-06	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—prostate cancer	3.69e-07	5e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTEN—prostate cancer	3.46e-07	4.69e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—EP300—prostate cancer	3.3e-07	4.47e-06	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—prostate cancer	3.05e-07	4.13e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.44e-07	3.31e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—prostate cancer	1.99e-07	2.7e-06	CbGpPWpGaD
